ADIPOQ and COVID-19: The results of the existing studies are often inconsistent, with some studies reporting higher levels of chemerin [14], resistin [15], adiponectin [16], while others show lower levels of chemerin [17], and similar concentrations of adiponectin in COVID-19 patients as compared with non-COVID-19 patients [18].